Theravance Biopharma, Inc. Income Taxes Receivable, Noncurrent
Theravance Biopharma, Inc. (TBPH) had Income Taxes Receivable, Noncurrent of $3.99 million as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes
us-gaap:IncomeTaxesReceivableNoncurrent · last filed 2021-02-26
- 2020-06-30: Income Taxes Receivable, Noncurrent $3.99M.
- 2020-03-31: Income Taxes Receivable, Noncurrent $3.97M.
- 2019-12-31: Income Taxes Receivable, Noncurrent $3.68M.
- 2019-09-30: Income Taxes Receivable, Noncurrent $3.66M.
| Period end | Income Taxes Receivable, Noncurrent |
|---|---|
| 2020-06-30 | $3.99M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.97M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.68M 10-K · filed 2021-02-26 |
| 2019-09-30 | $3.66M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.69M 10-Q · filed 2019-08-05 |
| 2018-09-30 | $3.13M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.14M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $3.32M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $8.19M 10-K · filed 2019-02-28 |
| 2017-09-30 | $8.07M 10-Q · filed 2017-11-08 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |